Gestational diabetes mellitus diagnosed at 24 to 28 weeks of gestation in older and obese Women: Is it too late?
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
AIM/BACKGROUND: The prevalence of elderly pregnancy and maternal obesity is increasing worldwide. In old and obese women, metabolic derangement affecting fetal growth might be present earlier than the diagnosis of gestational diabetes mellitus (GDM) or even before pregnancy. We thus investigated whether GDM diagnosed at 24-28 weeks of gestation had already affected fetal abdominal growth and, if so, whether elderly pregnancy and/or maternal obesity aggravate fetal abdominal obesity. METHODS: We retrospectively reviewed the medical records of 7820 singleton pregnant women who had been universally screened using a 50-g glucose challenge test (GCT) at 24-28 weeks of gestation, and underwent a 3-h 100-g oral glucose tolerance test (OGTT) if GCT were ≥140mg/dl. GDM and normal glucose tolerance (NGT) were diagnosed using the Carpenter-Coustan criteria. Fetal abdominal obesity was investigated by assessing the fetal abdominal overgrowth ratios (FAORs) of the ultrasonographically estimated gestational age (GA) of abdominal circumference per actual GA by the last menstruation period, biparietal diameter or femur length, respectively. Fetal abdominal overgrowth was defined as FAOR ≥ 90th percentile. The subjects were divided into four study groups: group 1 (age < 35 years and pre-pregnancy body mass index [BMI] < 25 kg/m2), group 2 (age < 35 years and ≥ 25), group 3 (age ≥ 35 years and BMI < 25), and group 4 (age ≥ 35 years and ≥ 25). RESULTS: The overall prevalence of GDM was 5.1%, with old and obese group 4 exhibiting the highest prevalence (22.4%). FAORs were significantly higher in the fetus of those with GDM than in the NGT subjects. But, in the subgroup analysis, only old and nonobese group 3 and old and obese group 4 with GDM exhibited significantly higher FAORs than the NGT subjects. Also, risk of fetal abdominal overgrowth was increased in group 3 and 4 subjects with GDM but not in young and nonobese group 1 GDM. The risk of fetal abdominal overgrowth significantly increased with maternal age >35 years, pre-pregnancy BMI >20kg/m2, and HbA1c >37.7 mmol/mol (5.6%). In multivariate analyses, maternal age and HbA1c were significantly associated with FAORs. CONCLUSION: GDM diagnosed at 24-28 weeks of gestation already affected fetal abdominal obesity in older and/or obese women, but not in younger and nonobese women. Our data suggest that selective screening and appropriate intervention of GDM earlier than 24-28 weeks of gestation might be necessary for high-risk old and/or obese women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012
Menke, A., Casagrande, S., Geiss, L., & Cowie, C. C. (2015) · JAMA · doi:10.1001/jama.2015.10029 · Cited by 2,362
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122
ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002501 · Cited by 1,820
Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective
Zhu, Y., & Zhang, C. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0699-x · Cited by 1,260
Hod, M., Kapur, A., Sacks, D. A., Hadar, E., Agarwal, M., Di Renzo, G. C., Roura, L. C., McIntyre, H. D., Morris, J. L., & Divakar, H. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(15)30033-3 · Cited by 767
Advanced maternal age and adverse pregnancy outcomes: A systematic review and meta-analysis
Lean, S. C., Derricott, H., Jones, R. L., & Heazell, A. E. P. (2017) · PLOS ONE · doi:10.1371/journal.pone.0186287 · Cited by 737
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study
The HAPO Study Cooperative Research Group (2009) · Diabetes · doi:10.2337/db08-1112 · Cited by 702
Lawrence, J. M., Contreras, R., Chen, W., & Sacks, D. A. (2008) · Diabetes Care · doi:10.2337/dc07-2345 · Cited by 658
Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline
Blumer, I., Hadar, E., Hadden, D. R., Jovanovič, L., Mestman, J. H., Murad, M. H., & Yogev, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2465 · Cited by 561
Increased fetal adiposity: a very sensitive marker of abnormal in utero development
Catalano, P. M., Thomas, A., Huston-Presley, L., & Amini, S. B. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(03)00828-7 · Cited by 519
Handelsman, Y., Mechanick, J. I., Blonde, L., Grunberger, G., Bloomgarden, Z. T., Bray, G. A., Dagogo-Jack, S., Davidson, J. A., Einhorn, D., Ganda, O., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.s2.1 · Cited by 513
Metzger, B. E. (1991) · Diabetes · doi:10.2337/diab.40.2.s197 · Cited by 481
Zhu, W.-W., Yang, H.-X., Wei, Y.-M., Yan, J., Wang, Z.-L., Li, X.-L., Wu, H.-R., Li, N., Zhang, M.-H., Liu, X.-H., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1157 · Cited by 338
Duran, A., Sáenz, S., Torrejón, M. J., Bordiú, E., del Valle, L., Galindo, M., Perez, N., Herraiz, M. A., Izquierdo, N., Rubio, M. A., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0179 · Cited by 335
U.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-10-200805200-00008 · Cited by 291
Sweeting, A. N., Ross, G. P., Hyett, J., Molyneaux, L., Constantino, M., Harding, A. J., & Wong, J. (2016) · Diabetes Care · doi:10.2337/dc15-0433 · Cited by 263
The Prevalence of Gestational Diabetes
Melchior, H., Kurch-Bek, D., & Mund, M. (2017) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2017.0412 · Cited by 185
Issues with the diagnosis and classification of hyperglycemia in early pregnancy
McIntyre, H. D., Sacks, D. A., Barbour, L. A., Feig, D. S., Catalano, P. M., Damm, P., & McElduff, A. (2016) · Diabetes Care · doi:10.2337/dc15-1887 · Cited by 181 · cited 1×
“…recommendation is accepted by the WHO [11]and the Endocrine Society [6],but early GDM, which is a lesser degree of hyperglycemia detected during the initial prenatal visit, is highly debatable with regard to the screening time, diagnostic criteria, intensity of treatment, and risk factors [63–65].”
on behalf of the DALI Core Investigator group, Egan, A. M., Vellinga, A., Harreiter, J., Simmons, D., Desoye, G., Corcoy, R., Adelantado, J. M., Devlieger, R., Van Assche, A., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4353-9 · Cited by 152
Feldman, R. K., Tieu, R. S., & Yasumura, L. (2016) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000001132 · Cited by 105
Endocrine Disruptors: A Potential Risk Factor for Gestational Diabetes Mellitus
Lambers, D., Baccarelli, A., Khoury, J., Macaluso, M., Ho, S.-M., & Ehrlich, S. (2016) · American Journal of Perinatology · doi:10.1055/s-0036-1586500 · Cited by 104
Glycosylated haemoglobin for screening and diagnosis of gestational diabetes mellitus
Khalafallah, A., Phuah, E., Al-Barazan, A. M., Nikakis, I., Radford, A., Clarkson, W., Trevett, C., Brain, T., Gebski, V., & Corbould, A. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011059 · Cited by 86
Risk factor screening for gestational diabetes mellitus based on the 2013 WHO criteria
Benhalima, K., Van Crombrugge, P., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., De Block, C., et al. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0117 · Cited by 60
Gestational diabetes in primiparous women–impact of age and adiposity: a register‐based cohort study
Laine, M. K., Kautiainen, H., Gissler, M., Raina, M., Aahos, I., Järvinen, K., Pennanen, P., & Eriksson, J. G. (2018) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.13271 · Cited by 52
Kim, M. H., Kwak, S. H., Kim, S.-H., Hong, J. S., Chung, H. R., Choi, S. H., Kim, M. Y., & Jang, H. C. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0192 · Cited by 50
Screening for gestational diabetes mellitus in Korea
Jang, H. C., Cho, N. H., Jung, K. B., Oh, K. S., Dooley, S. L., & Metzger, B. E. (1995) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(95)02524-g · Cited by 48
Sweeting, A. N., Ross, G. P., Hyett, J., Molyneaux, L., Tan, K., Constantino, M., Harding, A. J., & Wong, J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2951 · Cited by 47
Costa, E., Kirckpartick, C., Gerday, C., De Kempeneer, A., Derisbourg, S., Vercoutere, A., Haumont, S., Pintiaux, A., & Daelemans, C. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2406-4 · Cited by 15
Cited by
Gestational diabetes mellitus - A metabolic and reproductive disorder
Choudhury, A. A., & Devi Rajeswari, V. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112183 · Cited by 442
Kim, W., Park, S. K., & Kim, Y. L. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0078 · Cited by 17
Self-citationCosta, E., Kirckpartick, C., Gerday, C., De Kempeneer, A., Derisbourg, S., Vercoutere, A., Haumont, S., Pintiaux, A., & Daelemans, C. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2406-4 · Cited by 15
Thomakos, P., Kepaptsoglou, O., Korantzis, A., Trouva, A., Sklavounos, I., Trouvas, D., Taraoune, N., Barreto, C., & Zoupas, C. S. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.107914 · Cited by 8
Metadata
- Authors
- Kim, W., Park, S. K., & Kim, Y. L.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-12-16
- Volume
- 14
- Issue
- 12
- Pages
- e0225955
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2995329400
- Cited by
- 52
- References
- 33
- FWCI
- 6.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.